208 related articles for article (PubMed ID: 20978448)
1. Polymorphisms and haplotypes in the XRCC1 gene and the risk of advanced non-small cell lung cancer.
Kim IS; Lee GW; Kim DC; Kim HG; Kim S; Oh SY; Kim SH; Kwon HC
J Thorac Oncol; 2010 Dec; 5(12):1912-21. PubMed ID: 20978448
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
3. No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population.
Sun Y; Zhang YJ; Kong XM
Asian Pac J Cancer Prev; 2013; 14(9):5171-4. PubMed ID: 24175795
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
5. The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population.
Yin J; Vogel U; Ma Y; Qi R; Sun Z; Wang H
Lung Cancer; 2007 May; 56(2):153-60. PubMed ID: 17316890
[TBL] [Abstract][Full Text] [Related]
6. TGFBR1 haplotypes and risk of non-small-cell lung cancer.
Lei Z; Liu RY; Zhao J; Liu Z; Jiang X; You W; Chen XF; Liu X; Zhang K; Pasche B; Zhang HT
Cancer Res; 2009 Sep; 69(17):7046-52. PubMed ID: 19690145
[TBL] [Abstract][Full Text] [Related]
7. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.
Liu G; Zhou W; Park S; Wang LI; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer; 2004 Dec; 101(12):2802-8. PubMed ID: 15534883
[TBL] [Abstract][Full Text] [Related]
8. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
9. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
[TBL] [Abstract][Full Text] [Related]
10. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.
Ito H; Matsuo K; Hamajima N; Mitsudomi T; Sugiura T; Saito T; Yasue T; Lee KM; Kang D; Yoo KY; Sato S; Ueda R; Tajima K
Carcinogenesis; 2004 Aug; 25(8):1395-401. PubMed ID: 15044328
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
[TBL] [Abstract][Full Text] [Related]
12. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
13. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
14. Assoication of XRCC1 gene polymorphisms with risk of non-small cell lung cancer.
Kang S; Ma Y; Liu C; Cao C; Hanbateer ; Qi J; Li J; Wu X
Int J Clin Exp Pathol; 2015; 8(4):4171-6. PubMed ID: 26097609
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.
Sun X; Li F; Sun N; Shukui Q; Baoan C; Jifeng F; Lu C; Zuhong L; Hongyan C; YuanDong C; Jiazhong J; Yingfeng Z
Lung Cancer; 2009 Aug; 65(2):230-6. PubMed ID: 19157633
[TBL] [Abstract][Full Text] [Related]
16. 8-Oxoguanine incision activity is impaired in lung tissues of NSCLC patients with the polymorphism of OGG1 and XRCC1 genes.
Janik J; Swoboda M; Janowska B; Cieśla JM; Gackowski D; Kowalewski J; Olinski R; Tudek B; Speina E
Mutat Res; 2011 May; 709-710():21-31. PubMed ID: 21376741
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
18. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
Landvik NE; Hart K; Skaug V; Stangeland LB; Haugen A; Zienolddiny S
Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
[TBL] [Abstract][Full Text] [Related]
19. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
